Federal Register Notice: FDA will hold a public meeting 6/2 in conjunction with the National Institutes of Health on how nthe two agencies can better collaborate to advance the translation of biomedical research discoveries into approved diagnostics and therapies as well as promote science to enhance the evaluation tools used for regulatory review. A newly formed NIH-FDA Joint Leadership Council will help ensure that regulatory considerations form an increasing component of biomedical research planning, and that the latest science is integrated into the regulatory review process. The meeting will be held from 8:30 a.m. to 12:30 p.m. at FDA, 10903 New Hampshire Ave., Bldg. 31, Rm. 1503C, Silver Spring, MD Electronic comments can be submitted at http:// www.regulations.gov or written comments can be sent to the Division of Dockets Management (HFA- 305), FDA, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Contact Rakesh Raghuwanshi, (301) 796-4769. To view this notice, click here.